• Harvard Diabetes Comorbidities and Complications 2023

Harvard Diabetes Comorbidities and Complications 2023 (Videos)

Harvard Diabetes Comorbidities and Complications 2023 (Videos)

$70.00 USD
$70.00 USD
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out
Harvard Diabetes Comorbidities and Complications 2023

Harvard Diabetes Comorbidities and Complications 2023 (Videos)

$70.00
$70.00
SAVE Liquid error (snippets/price line 116): Computation results in '-Infinity'% Sold out

  • Share positive thoughts and feedback from your customer.

    Author

  • Share positive thoughts and feedback from your customer.

    Author

  • Share positive thoughts and feedback from your customer.

    Author
    View full details

    Harvard Diabetes Comorbidities and Complications 2023 (Videos)



    Harvard Diabetes Comorbidities and Complications 2023 Comprehensive Updates for State-of-the-Art Diagnosis, Management, and Prevention Diabetes Comorbidities and Complications will be held online, using live streaming, electronic Q&A, and other remote learning technologies. In addition to their clinical expertise, faculty have been chosen for their inspirational teaching skills and their ability to provide specific recommendations

    • This comprehensive course provides education and updates to optimize your care of patients with diabetes and these conditions:

      • Obesity
      • Cardiovascular Disease
      • Heart Failure
      • Coronary Artery Disease
      • Cerebrovascular Disease
      • Hypertension
      • Hyperglycemia
      • Hypoglycemia
      • Dyslipidemia
      • Metabolic-Associated Fatty Liver Disease
      • Chronic Kidney Disease

    Sessions are led by experts in these conditions and their impact on the patient with diabetes. Faculty deliver practical education that is focused on:
    • Advancing your knowledge of diabetes comorbidities and complications
    • Delivering state-of-the-art approaches to evaluation and management of the patient with diabetes and these conditions
    • Identifying practical strategies to reduce the risk of diabetes comorbidities and complications
    • Optimizing clinical decision-making
    • Improving patient outcomes

    In addition to their clinical expertise, faculty have been chosen for their inspirational teaching skills and their ability to provide specific recommendations to incorporate the vast number of recent updates covered in this program into day-to-day clinical practice.

    EDUCATIONAL HIGHLIGHTS

    This program provides strategies, updates, and new practice recommendations to improve your care of patients with (and at risk for) diabetes complications and comorbidities. Participants can rely on this program for updates that ensure state-of-the-art:
    • PREVENTION and RISK REDUCTION
    • DIAGNOSIS
    • MANAGEMENT
    • USE of the NEWEST DIABETES DRUGS, TECHNOLOGIES, and DEVICES 
    PREVENTION and RISK REDUCTION
    • New algorithms for evaluating cardiovascular and renal risk in patients with diabetes
    • Medical treatment and lifestyle interventions to prevent:
      • Cardiovascular disease
      • Kidney disease
      • Cerebrovascular disease
      • Hyper- and hypoglycemia
    • Medication interactions: avoiding adverse outcomes
    • Impact of the newest pharmacological tools to reduce CV and renal disease development and progression
    DIAGNOSIS

    Expanded options for diagnosis of:
    • Coronary artery disease
    • Heart failure
    • Cerebrovascular disease
    • Chronic kidney disease
    • Metabolic-associated fatty liver disease
    • Hypoglycemia
    MANAGEMENT
    • Adjusting pharmacological therapies in the patient with diabetes complications
    • Evaluating, managing, and monitoring diabetic CKD
    • Obesity management: when to consider new therapeutic and surgical options
    • Diagnosis and management of coronary artery disease in the patient with diabetes
    • Management of kidney disease in the patient with diabetes
    • Hypertension and cholesterol management: customizing targets and treatment strategies for each patient
    • Heart failure: improving patient functional capacity with combined therapies
    • Management of cerebrovascular disease
    • Updates in the management of hyper- and hypoglycemia
    • Current guidelines for treating metabolic-associated fatty liver disease
    • Combining innovative therapeutic combinations with traditional approaches
    • Strategies to assess and manage interacting comorbidities
    INCORPORATING NEW DRUGS, TECHNOLOGIES, and DEVICES INTO PRACTICE
    • The expanded roles of SGLT-2 inhibitors, MRA, and GLP-1 RA in treating CV and renal disease
    • Practical recommendations for the use of GLP-1 RA, SGLT-2 inhibitors, and MRA
    • Advances in glucose monitors, insulin pumps, and diabetes apps

     

    SOCIAL, RACIAL, SEXUAL, and CULTURAL DIFFERENCES IN DIABETES CARE NEEDS

    We are committed to offering the best practices for health care equity and the needs of diverse patient populations. Highlights include:
    • Management of diabetes and related disorders in diverse racial/ethnic populations
    • Recognizing biases: strategies for achieving equity and addressing disparities
    • Establishing and maintaining connections with patients
    This CME program will be held online using live streaming, electronic Q&A, and other remote learning technologies.

    Monday, July 31, 2023

    • Welcome and Introduction

      A. Enrique Caballero, MD and Romela Petrosyan, MD

    OBESITY MANAGEMENT


    Medical Treatment of Obesity: Updates and Best Practices for Individualizing Therapies
    Bartolome Burguera, MD

    Advances in Surgical Treatment of Obesity and Why and When to Refer Patients with Diabetes
    Philip Schauer, MD

    Q & A and Clinical Case Discussion
    Bartolome Burguera, MD and Philip Schauer, MD

    Concurrent Breakout Sessions

    Choose either of the two breakout sessions listed below
    Both sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.

    CARDIOVASCULAR -


    Diagnosis and Management of Heart Failure in the Patient with Diabetes: What Every Physician Now Needs to Know
    Akshay Desai, MD

    METABOLIC - Updates in Continuous Glucose Monitoring and Insulin Pumps in Diabetes Management
    Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES, FADCES, FCCP

    ADVANCES in HYPERTENSION MANAGEMENT

    Hypertension Management in the Patient with Diabetes: A Practical Approach
    Naomi Fisher, MD

    Wrap-Up of Day 1
    Course Directors

    Tuesday, August 1, 2023


    Welcome and Introduction to Day 2 Activities
    A. Enrique Caballero, MD and Romela Petrosyan, MD

    UPDATES in DIABETES MANAGEMENT


    Adjusting Pharmacological Therapies in the Patient with Diabetes Complications
    Marie McDonnell, MD

    Updates in the Prevention and Management of Hypoglycemia
    Devin Steenkamp, MD

    Q & A and Clinical Case Discussion
    Marie McDonnell, MD and Devin Steenkamp, MD

    Concurrent Breakout Sessions


    Choose either of the two breakout sessions listed below
    Both sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.

    CARDIOVASCULAR - Diagnosis and Management of Coronary Artery Disease in the Patient with Diabetes: Practical Tools for the Busy Clinician
    Christopher Cannon, MD

    METABOLIC - Weight Variability and Diabetes Complications
    Antonio Ceriello, MD

    ADVANCES in the MANAGEMENT of DYSLIPIDEMIA


    Updates, Innovations, and Advances for the Management of Dyslipidemia in the Patient with Diabetes
    Om Ganda, MD
    Wrap-Up of Day 2
    Course Directors

    Wednesday, August 2, 2023


    Welcome and Introduction to Day 3 Activities
    A. Enrique Caballero, MD and Romela Petrosyan, MD

    UPDATES for CARDIOVASCULAR and RENAL RISK REDUCTION


    in the PATIENT with DIABETES
    Practical Recommendations for the Use of GLP-1 RA in Clinical Practice and Their Impact on CV and Renal Risk Reduction
    Vanita Aroda, MD

    KEYNOTE: The Expanded Role of SGLT-2 Inhibitors in Diabetes, Cardiovascular, and Renal Disease: Implications for Clinical Practice
    Deepak Bhatt, MD

    KEYNOTE: The Role of MRA Antagonists in CV and Renal Risk Reduction in the Patient with Diabetes: Recent Data and Practical Implications
    George Bakris, MD

    Q & A and Clinical Case Discussion
    Vanita Aroda, MD, Deepak Bhatt, MD, and George Bakris, MD

    Concurrent Breakout Sessions


    Choose either of the two breakout sessions listed below
    Both sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.

    CARDIOVASCULAR - Updates in the Evaluation and Management of Peripheral Vascular Disease in the Patient with Diabetes
    Allen D. Hamdan, MD

    METABOLIC - Diabetes in Pregnancy: New Diagnosis and Treatment Guidelines
    Florence Brown, MD

    THE EDWARD S. HORTON LECTURE


    Management of Diabetes and Related Disorders in Diverse Racial/Ethnic Populations
    A. Enrique Caballero, MD

    Wrap-Up of Day 3
    Course Directors

    Thursday, August 3, 2023


    Welcome and Introduction to Day 4 Activities
    A. Enrique Caballero, MD and Romela Petrosyan, MD

    CHRONIC KIDNEY DISEASE


    in the PATIENT with DIABETES
    Evaluation and Monitoring of Diabetic CKD
    Romela Petrosyan, MD
    KEYNOTE: Current Clinical Guidelines for the Management of CKD in Diabetes
    Katherine R. Tuttle, MD, FASN, FACP, FNKF

    Q & A and Clinical Case Discussion
    Romela Petrosyan, MD and Katherine R. Tuttle, MD, FASN, FACP, FNKF

    Concurrent Breakout Sessions


    Choose either of the two breakout sessions listed below
    Both sessions will be recorded as they are live streamed and will be available for viewing in the course video archive for 60 days.

    CARDIOVASCULAR - Evaluation and Management of Sexual Dysfunction in Patients with Diabetes
    Martin N. Kathrins, MD

    METABOLIC - Updates and Best Practices for State-of-the-Art Insulin Therapy
    Guillermo Umpierrez, MD

    ADVANCES in NON-ALCOHOLIC FATTY LIVER DISEASE


    Diagnosis and Management of Non-Alcoholic Fatty Liver Disease
    Ken Cusi, MD

    Closing Remarks
    Course Directors